FOLFOX 4 + CETUXIMAB IN UNTREATED PATIENTS WITH ADVANCED COLO-RECTAL TUMOUR. A PHASE II MULTICENTER STUDY OF THE GRUPPO ONCOLOGICO DELL’ITALIA MERIDIONALE

ABSTRACT: Primary objectives: PERCENTAGE OF OBJECTIVE RESPONSES Primary endpoints: TO ESTIMATE THE PERCENTAGE OF OBJECTIVE RESPONSES

DISEASE(S): Colorectal Cancer Nos,Advanced Colo-rectal Tumour

PROVIDER: 2516472 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR